Schellenberg Wittmer advised Abacus Medicine Group, a Danish group active in the field of modern healthcare, on the acquisition of Swiss Cardio Technologies AG. The Swiss company specializes in cardioplegia, a technique used to intentionally and temporarily interrupt cardiac activity in order to facilitate bypass surgery or other cardiac and aortic procedures.